Leading the charge against cancer in Arizona
News
Many Non-Hodgkin’s Lymphoma Patients Can Skip Radiation, Suggests Study Led by UArizona Researcher
Results from a SWOG Cancer Research Network study, led by Daniel Persky, MD, found many patients with the most common type of non-Hodgkin’s lymphoma can skip radiation treatment, reducing both costs and the time to heal from treatment. Read More
UArizona Cancer Center Receives $6.85M Grant to Continue Native American Cancer Research, Training, Outreach Program
Since 2002, the UArizona Cancer Center has partnered with Northern Arizona University through the Partnership for Native American Cancer Prevention (NACP) to alleviate the unequal burden of cancer among Native Americans. NACP is one of 16 National Cancer Institute (NCI) Partnerships to Advance Cancer Health Equity (PACHE), but the NACP partnership between the UArizona Cancer Center and NAU is the only one dedicated solely to the Native American population. Read More
UA Cancer Center Receives $8.6M Grant to Lead One of Three NCI Clinical Trials Networks
Under this funding mechanism, the UA Cancer Center serves as a lead academic organization with 12 affiliated organizations working together to perform early-phase cancer-prevention clinical trials. The network is composed of a team of physicians from diverse specialties, statisticians, clinical staff, data managers, pathologists, translational scientists and other personnel with extensive experience in early-phase (phase 0, I or II) cancer-prevention clinical trials. Read More
Cancer in Arizona
Patient Stories
Patient Profile: Kristie Kilkelly
For Kristie Kilkelly, knowledge is power. She provides her high school history students with the tools needed to gather knowledge for themselves. She places a high premium on scientific knowledge. And she understands from firsthand experience that self-knowledge can be lifesaving.
Prevention
Research
UA Targeting Rhabdomyosarcoma, a Rare Pediatric Cancer With Few Treatment Options
UA Cancer Center researcher harnesses “big data” to identify targeted treatments for rhabdomyosarcoma, a rare cancer that mostly strikes children and teenagers.
As Dry as the Desert in July
A fleeting nuisance for most, dry mouth can wreak havoc on a head-and-neck cancer survivor’s quality of life
‘Evil’ Proteins Are a Force for Good in Estrogen Receptor-Positive Breast Cancer
University of Arizona Cancer Center researchers clarify questions surrounding estrogen’s role in breast cancer, which could lead to more precise treatments for ER-positive breast cancers.